Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
59 /100
HIGH RISK
Score updated Jul 28, 2026

BFRI — Biofrontera Inc. Dilution Risk Tracker

Track BFRI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BFRI — Get alerts when the score changes →

As of July 28, 2026, Biofrontera Inc. (BFRI) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. Biofrontera Inc. has a market capitalization of $11.34M, 12.80M shares outstanding, 12 institutional holders tracked. Key dilution vectors include approximately 7 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split 65%
• 50-day avg $0.97 below $1 exchange minimum
• 7 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (7mo)
🔔 Track BFRI — Get forecast alerts →

Market Data

Market Cap$11.34M
Shares Outstanding12.80M
Float8.06M
Cash$6.32M
Debt$296.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 4.6% shares (2026Q1 vs prior)
12 institutional holders · 2.44M shares
#1 Rosalind Advisors, Inc. 1.16M shares
#2 AIGH Capital Management LLC 915.2K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 109.3K shares
+ 9 more holders Sign up free to view →

Short Interest

Short Interest24.2K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2024-12-31
4 INSIDER TRANSACTION 2026-03-06
4 INSIDER TRANSACTION 2026-03-06
4 INSIDER TRANSACTION 2026-03-06
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for BFRI Shareholders

Biofrontera Inc. (BFRI) has a DilutionScore of 59/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 28, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: BFRI has approximately 7 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for BFRI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for BFRI alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding BFRI's Dilution Risk Factors

Primary Risk Drivers

The most significant dilution risks for Biofrontera Inc. stem from its Offering Ability and Cash Runway scores. Offering Ability is at a concerning level, indicating the company has the capacity to raise capital through new equity offerings, which typically dilute existing shareholders. Cash Runway, while not at maximum risk, is still elevated and signals that the company’s cash reserves are limited, potentially necessitating further funding through equity issuance. Together, these factors suggest an environment where additional capital is likely needed, increasing the probability of share dilution.

Factors Currently Not a Concern

The Float Risk factor is at a low level, suggesting that the company’s publicly traded shares are not heavily concentrated among a small number of holders. Should the float become more concentrated or if significant insider selling occurs, this could escalate risk. Additionally, Warrant Exposure and Convertible Note Risk are both low, indicating minimal dilution from these instruments. However, any new warrant issuance or convertible note offering would quickly elevate these scores.

SEC Filings to Watch

Several filing types are critical to monitor for BFRI. An S-3 registration statement would signal a potential large-scale equity offering, directly increasing dilution risk. A 424B5 filing often accompanies such offerings and indicates the company is preparing to sell securities. An 8-K Item 1.01 filing could report new equity issuances or capital raises, while a 10-Q filing may disclose updated cash reserves or strategic plans that could imply future dilution.

How Dilution Happens

When BFRI issues new shares to raise capital, existing shareholders’ ownership percentage decreases. If Offering Ability is high and Cash Runway is low, the company may be forced to issue equity more frequently, increasing share count. Each new issuance dilutes the value of pre-existing holdings, especially if the company raises funds at a price below current market value. This process directly reduces earnings per share and can diminish investor confidence.

What Would Make This Worse

A significant worsening of BFRI’s risk profile could occur if multiple equity offerings are initiated in quick succession or if convertible notes convert into common stock. Additionally, a drop in cash reserves below the current 6.8-month threshold would intensify pressure to raise capital, leading to more frequent dilution events. If the company begins issuing warrants or convertible debt with favorable terms, it could create further downward pressure on share price and ownership dilution.

Key Insight

BFRI's elevated Offering Ability combined with limited cash runway creates a high probability of future equity issuance, which directly impacts existing shareholders through dilution.

How to Monitor BFRI for Dilution Risk

What This Risk Level Means

A high dilution risk profile for Biofrontera Inc. signals significant exposure to potential ownership dilution, particularly for a micro-cap operating company. At this level, the company’s capital structure is under pressure from various mechanisms that could reduce existing shareholders' equity stakes. For such small companies, even modest increases in outstanding shares can have outsized effects on share price and voting power. The elevated risk is compounded by factors like offering ability and cash runway, indicating both a willingness to raise capital and a need for it, which often translates into dilutive actions.

What Typically Happens Next

Companies with this profile often proceed through a series of financing activities that increase share count. Common next steps include shelf registrations or ATM programs, which allow the company to sell shares on the open market at prevailing prices. Warrant exercises and convertible note conversions are also typical mechanisms that can quickly dilute existing shareholders. These actions usually occur within 12–24 months of initial risk signals, especially when companies face cash constraints or are pursuing growth initiatives.

Monitoring Playbook

To track BFRI effectively, use DilutionWatch to monitor score changes and key events. Set alerts for any increase in Offering Ability, Cash Runway, or Warrant Exposure scores. Check the company’s SEC filings weekly, particularly Form S-1, S-3, and 8-Ks. Monitor Shelf & ATM Monitor for announcements of new offerings or sales. When thresholds are hit, review recent capital structure changes and assess whether new equity is being issued at below-market prices.

Early Warning Signals

Watch For

Any sudden increase in Offering Ability or Cash Runway scores, especially if accompanied by a Form S-1 filing or an 8-K announcement of new warrants or convertible notes.

  • A Form S-1 or S-3 filing indicating a planned equity offering
  • Unusual warrant exercise activity in recent 8-K reports
  • An increase in convertible note conversions or new note issuances

What a Positive Resolution Looks Like

A positive shift in BFRI’s dilution risk profile would occur if the company successfully raises capital through non-dilutive means, such as debt financing or strategic partnerships. A reduction in outstanding warrants or convertible notes, or a significant paydown of existing debt, could also improve the score. Additionally, an extended cash runway (e.g., moving from 65/100 to below 30/100) would indicate improved financial stability and reduced need for further equity issuance.

Full SEC filing analysis available with free account  →
Track BFRI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BFRI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BFRI
BFRI FDA Catalyst Timeline & Biotech Grade — BiotechSignsBFRI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.